A low-glycemic-index diet reduces plasma plasminogen activator inhibitor-1 activity, but not tissue inhibitor of proteinases-1 or plasminogen activator inhibitor-1 protein, in overweight women.
Study Goal
The researchers aimed to determine whether a low-glycemic-index (LGI) diet reduces plasma PAI-1 and TIMP-1 concentrations in overweight women compared to a high-glycemic-index (HGI) diet.
Results Summary
The LGI diet significantly reduced fasting plasma PAI-1 activity compared to the HGI diet, suggesting potential cardiovascular benefits. No significant changes were observed in TIMP-1 concentrations or post-meal test PAI-1 and TIMP-1 levels between groups.
Population
Overweight women (BMI: 27.5 ± 0.23 kg/m²).
Effective Dosage
Ad libitum consumption (no specific dosage mentioned).
Duration
10 weeks.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
low-glycemic-index (LGI) diet | decrease | PAI-1 activity | overweight women | - | decreased | #1 |
low-glycemic-index (LGI) diet | decrease | PAI-1 activity | overweight women | - | was significantly different between groups | #2 |
low-glycemic-index (LGI) diet | decrease | PAI-1 antigen | overweight women | - | followed the same trend | #3 |
low-glycemic-index (LGI) diet | no change | PAI-1 antigen | overweight women | - | no significant difference was observed between groups | #4 |
low-glycemic-index (LGI) diet | no change | plasma TIMP-1 concentrations | overweight women | - | no difference was observed between groups | #5 |
low-glycemic-index (LGI) diet | no change | PAI-1 and TIMP-1 concentrations after the 4-h meal test | subgroup of 29 women | - | were not significantly different between groups | #6 |
low-glycemic-index (LGI) diet | decrease | fasting plasma PAI-1 activity | overweight women | - | reduces | #7 |
low-glycemic-index (LGI) diet | decrease | the adverse cardiovascular effects of obesity | - | - | may be useful for diminishing | #8 |
BACKGROUND: The development of obesity has been suggested to involve plasminogen activator inhibitor-1 (PAI-1) and tissue inhibitor of proteinases-1 (TIMP-1). Plasma PAI-1 is elevated in obesity. A low-glycemic-index (LGI) diet may have a beneficial effect on obesity through a decrease in plasma PAI-1, but whether it affects plasma TIMP-1 in healthy humans has not been studied. OBJECTIVE: We investigated whether a 10-wk intake of an LGI or a high-glycemic-index (HGI), high-carbohydrate, low-fat, ad libitum diet is associated with decreases in plasma PAI-1 and TIMP-1 concentrations in overweight women. DESIGN: Forty-four overweight women [body mass index (BMI; in kg/m2): 27.5+/-0.23] were randomly assigned to consume an HGI or an LGI diet for 10 wk. A subgroup of 29 women was assigned to participate in an additional 4-h meal test on the last day of the 10-wk intervention. RESULTS: PAI-1 activity decreased after 10 wk of the LGI diet and was significantly different between groups. Changes in PAI-1 antigen followed the same trend, but no significant difference was observed between groups. No difference in plasma TIMP-1 concentrations was observed between groups. PAI-1 and TIMP-1 concentrations after the 4-h meal test were not significantly different between groups. CONCLUSION: An LGI diet reduces fasting plasma PAI-1 activity and therefore may be useful for diminishing the adverse cardiovascular effects of obesity. This trial was registered at clinicaltrials.gov as NCT00324090.